Clinical trials · Philadelphia, PA
Sepsis clinical trials in Philadelphia
We’re tracking 10 recruiting sepsis studies with a site in or near Philadelphia — including Phase 1, Phase 2 and Phase 2/Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Philadelphia
- NCT06517810Recruiting
QUELIMMUNE pediatric surveillance registry
This registry tracks children treated with QUELIMMUNE therapy to see how well it works over time. It helps doctors learn more about the treatment's safety and effects in kids.
Philadelphia, PennsylvaniaAges Up to 22 years - NCT02469662Recruiting
Study of outcomes after Nexel total elbow replacement
This study looks at how well the Nexel total elbow replacement works over time for people who need an elbow replacement due to pain, damage, or instability. It may help the doctors understand which patients benefit most and what results to expect.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06521502Recruiting
Studying inflammation in the heart and lungs in the ICU
This study collects blood samples from people in the ICU with sudden heart or lung problems caused by inflammation. The goal is to learn more about these conditions and improve future treatments.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05975671Recruiting
Survey in pediatric ICU to reduce upfront vancomycin use
This study is a survey and quality-improvement effort in participating children’s intensive care units. It aims to understand and change how doctors decide to start vancomycin (an antibiotic) when sepsis is suspected, to improve care and avoid unnecessary use.
Philadelphia, PennsylvaniaAges Any age - NCT07084129RecruitingPhase 1
Vancomycin and kidney injury study for children with sepsis
This trial tests a different way of giving vancomycin to children with sepsis to reduce the risk of kidney injury. It compares standard dosing to an approach that adjusts dose based on how the kidneys are working.
Philadelphia, PennsylvaniaAges 1 month–17 years - NCT07215702RecruitingPhase 2
Testing a drug for kidney injury from sepsis in the ICU
This trial tests if a new drug, AZD4144, can help people with sepsis-related acute kidney injury in the ICU. It aims to see if the drug can improve kidney recovery and reduce complications.
Philadelphia, PennsylvaniaAges 18–80 - NCT05267821RecruitingPhase 2/Phase 3
Testing anakinra to reduce inflammation in pediatric sepsis MODS
This study tests whether a medicine called anakinra can “turn down” harmful inflammation in children with severe illness from sepsis. It aims to improve organ function when multiple organs are starting to fail.
Philadelphia, PennsylvaniaAges 1 day–17 years - NCT04855786Recruiting
Drain lymph fluid to reduce inflammation in septic shock
This study tests whether draining fluid from a chest lymph channel can lower inflammation chemicals (cytokines) in people with septic shock. It’s done using a procedure and aims to see if this helps stabilize the body’s inflammatory response.
Philadelphia, PennsylvaniaAges 18–80 - NCT06694181Recruiting
Safe and explainable AI for heart, sepsis, and breast cancer patients
This trial uses artificial intelligence (AI) to create prediction models for three groups: cardiology patients, sepsis patients, and breast cancer patients. It aims to make these models safe and easy to understand for doctors.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06772675Recruiting
Reducing vancomycin in NICU babies
This study asks NICUs to reduce the use of the antibiotic vancomycin. It's for hospital units that are part of certain networks and agree to follow the study plan.
Philadelphia, PennsylvaniaAges 18 years+
Hear when a new Sepsis trial opens near Philadelphia, PA
We’ll email you when one opens near Philadelphia, PA — at most once a week, no account needed, unsubscribe anytime.
Sepsis trials in other cities
Where these studies are running near Philadelphia
Institutions with a site for the recruiting sepsis studies listed above.
- Children's Hospital of Philadelphia · 4 studies
- University of Pennsylvania · 4 studies
- Chester County Hospital
- Penn Medicine Princeton Medical Center
- Pennsylvania Hospital
- Research Site
- Rothman Orthopaedic Institute
What taking part in a sepsis study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting sepsis studies in Pennsylvania.
Common questions
- Are there sepsis clinical trials near Philadelphia?
- Yes. We're currently tracking 10 recruiting sepsis studies with a site near Philadelphia, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a sepsis study near Philadelphia?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Philadelphia to take part?
- Not necessarily. These studies have a site near Philadelphia, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a sepsis trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New sepsis studies open near Philadelphia regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.